Table 1. Clinical characteristic according to the ALK variant.
| Characteristics | Values (n=31) | P value | |
|---|---|---|---|
| V1/2 (n=15) | Others (n=16) | ||
| Age, years | 0.160 | ||
| Median | 45.0 | 54.0 | |
| Range | 30.0–77.0 | 27.0–73.0 | |
| Sex, n (%) | 0.320 | ||
| Male | 11 (73.3) | 9 (56.3) | |
| Female | 4 (26.7) | 7 (43.7) | |
| Smoking history, n (%) | 0.970 | ||
| Never smoker | 8 (53.3) | 13 (81.3) | |
| Ever smoker | 7 (46.7) | 3 (18.7) | |
| Pathology type, n (%) | 0.316 | ||
| Adenocarcinoma | 14 (93.3) | 13 (81.3) | |
| Not adenocarcinoma | 1 (6.7) | 3 (18.7) | |
| Stage, n (%) | 0.916 | ||
| IIIB/IV | 11 (73.3) | 12 (75.0) | |
| Postoperative recurrent, n (%) | 4 (26.7) | 4 (25.0) | |
| Treatment line, n (%) | 0.745 | ||
| First | 6 (40.0) | 8 (50.0) | |
| ≥ Second | 7 (46.7) | 7 (43.8) | |
| Unknown | 2 (13.3) | 1 (6.2) | |
| Metastasis, n | 0.424 | ||
| Brain & bone | 7 | 10 | |
| Others | 10 | 11 | |
| Unknown | 0 | 2 | |
| Treatment response, n (%) | 0.946 | ||
| PR | 8 (53.3) | 8 (50.0) | |
| SD | 3 (20.0) | 4 (25.0) | |
| Unknown | 4 (26.7) | 4 (25.0) | |
PR, partial response; SD, stable disease.